This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Dawson, L. Search for Related Content PubMed PubMed Citation Articles by Dawson, L. Pubmed/NCBI databases Medline Plus Health Information Polio and Post-Polio Syndrome Social Bookmarking                         What's this?

The Salk Polio Vaccine Trial of 1954: risks, randomization and public involvement in research

The Phoebe R. Berman Bioethics Institute, The John Hopkins University, 624 N. Broadway, Hampton House Rm. 352, Baltimore, MD 21205, USAdawsonl{at}mail.nih.gov

The year 2004 marks the "ftieth anniversary of the celebrated 1954 Salk polio vaccine trial. This enormous clinical trial, involving 1.8 million children, was carried out with the co-operation and assistance of hundreds of thousands of lay volunteers, along with medical professionals and local health departments throughout the USA. While the trial was an impressive public health achievement, "rmly establishing the ef"cacy of the killed virus vaccine and paving the way for eradication of the disease, it was not without controversy. This article recounts the story of this important early clinical trial and how the social and political conditions at the time affected its planning and execution.

Clinical Trials, Vol. 1, No. 1, 122-130 (2004)
DOI: 10.1191/1740774504cn010xx


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?